Back
Perspective Therapeutics Quote, Financials, Valuation and Earnings
$50 trade to make today with huge potential!
Click here to access my #1 options strategy for overnight wins starting with $50!
Buy
77
CATX
Perspective Therapeutics
Last Price:
1.67
Seasonality Move:
1.64%
7 Day Trial
ALL ACCESS PASS
$
7
America's Final Republican President
Click here to see his 2024 election prediction.Perspective Therapeutics Price Quote
$1.67
+0.09 (+5.7%)
(Updated: April 29, 2024 at 2:00 PM ET)
Perspective Therapeutics Key Stats
Buy
77
Perspective Therapeutics (CATX)
is a Buy
Day range:
$1.53 - $1.62
52-week range:
$0.21 - $1.77
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
0.00
P/B ratio:
12.33%
Volume:
4.7M
Avg. volume:
6M
1-year change:
174.97%
Market cap:
$927.3M
Revenue:
$0
EPS:
$-0.17
How Much Does Perspective Therapeutics Make?
Data Unavailable
Is Perspective Therapeutics Growing As A Company?
Data Unavailable
Perspective Therapeutics Stock Price Performance
-
Did Perspective Therapeutics Stock Go Up Last Month?
Perspective Therapeutics share price went up by 27.42% last month -
Did CATX's Share Price Rise Over The Last Year?
CATX share price rose by 174.97% over the past 1 year
What Is Perspective Therapeutics 52-Week High & Low?
-
What Is Perspective Therapeutics’s 52-Week High Share Price?
Perspective Therapeutics has traded as high as $1.77 over the past 52 weeks -
What Is Perspective Therapeutics’s 52-Week Low Share Price?
Perspective Therapeutics has traded as low as $0.21 over the past 52 weeks
Perspective Therapeutics Price To Free Cash Flow
Data Unavailable
Is It Risky To Buy Perspective Therapeutics?
-
How Much Debt Does Perspective Therapeutics Have?
Total long term debt quarterly is $1.7M -
How Much Cash Does Perspective Therapeutics Have?
Cash and short term investments quarterly total is $9.2M -
What Is Perspective Therapeutics’s Book Value Per Share?
Book value per share is 0.27
Is Perspective Therapeutics Cash Flow Positive?
-
What Is CATX Cash Flow From Operations?
Cash flow from operations (TTM) is -$36.9M -
What Is Perspective Therapeutics’s Cash Flow From Financing?
Cash flow from financing (TTM) is $785K -
What Is Perspective Therapeutics’s Cash Flow From Investing?
Cash flow from investing (TTM) is $24.4M
Perspective Therapeutics Return On Invested Capital
-
Is Management Doing A Good Job?
CATX return on invested capital is -49.97% -
What Is Perspective Therapeutics Return On Assets?
ROA measures how assets are converting to revenues and is -44.83% -
What Is CATX Return On Equity?
ROE is a measure of profitability and is -50.74%
Perspective Therapeutics Earnings Date & Stock Price
-
What Is Perspective Therapeutics's Stock Price Today?
A single share of CATX can be purchased today for 1.58 -
What Is Perspective Therapeutics’s Stock Symbol?
Perspective Therapeutics trades on the nyam under the ticker symbol: CATX -
When Is Perspective Therapeutics’s Next Earnings Date?
The next quarterly earnings date for Perspective Therapeutics is scheduled on May 6, 2024 -
When Is CATX's next ex-dividend date?
Perspective Therapeutics's next ex-dividend date is April 29, 2024 -
How To Buy Perspective Therapeutics Stock?
You can buy Perspective Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
Perspective Therapeutics Competitors
-
Who Are Perspective Therapeutics's Competitors?
Below is a list of companies who compete with Perspective Therapeutics or are related in some way:
Perspective Therapeutics Dividend Yield
Data Unavailable
Perspective Therapeutics Analyst Estimates
| YoY Growth | Past Surprise | |
|---|---|---|
| EPS: | 0% | 0% |
| Revenue: | 0% | -331.06% |
Analyst Recommendations
| Buy Recommendations: | 2 |
|---|---|
| Hold Recommendations: | 0 |
| Sell Recommendations: | 0 |
| Price Target: | 1.60 |
| Upside from Last Price: | 1.27% |